Company Five Prime Therapeutics, Inc.
Equities
FPRX
US33830X1046
Biotechnology & Medical Research
Business Summary
Number of employees: 51
Managers
Managers | Title | Age | Since |
---|---|---|---|
David Reese
CEO | Chief Executive Officer | 61 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 47,341,318 | 45,500,078 ( 96.11 %) | 769,289 ( 1.625 %) | 96.11 % |
Company contact information
Five Prime Therapeutics, Inc.
111 Oyster Point Boulevard
94080-7047, South San Francisco
+415 365 5600
http://www.fiveprime.comSector
1st Jan change | Capi. | |
---|---|---|
-1.51% | 104B | |
+3.22% | 97.42B | |
+1.02% | 22.2B | |
-16.53% | 21.23B | |
-8.72% | 18.33B | |
-42.33% | 16.35B | |
-20.09% | 15.06B | |
+5.47% | 13.98B | |
+28.85% | 11.66B |